These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3291289)

  • 1. Critical hypotheses on cyclosporine in bone marrow transplantation.
    Speck B; Gratwohl A; Tichelli A; Würsch A
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):505-15. PubMed ID: 3291289
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cyclosporine in allogeneic bone marrow transplantation in children].
    Kojima S; Fukuda M; Horibe K; Matsuyama K
    Rinsho Ketsueki; 1987 Sep; 28(9):1576-82. PubMed ID: 3325658
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of cyclosporin A in 5 leukemia patients receiving allogeneic bone marrow transplantation].
    Akao Y; Sao H; Tahara T; Yoshikawa H; Yoshikawa S; Morishima Y; Hiraiwa A; Naoe T
    Rinsho Ketsueki; 1984 Sep; 25(9):1417-26. PubMed ID: 6394783
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized prospective trial comparing cyclosporine and methotrexate given for prophylaxis of graft-versus-host disease after bone marrow transplantation.
    Biggs JC; Atkinson K; Gillett E; Downs K; Concannon A; Dodds A
    Transplant Proc; 1986 Apr; 18(2):253-5. PubMed ID: 3515659
    [No Abstract]   [Full Text] [Related]  

  • 5. [Marrow transplantation in leukemia-recent trends].
    Gratwohl A; Signer E
    Monatsschr Kinderheilkd; 1982 Nov; 130(11):810-3. PubMed ID: 6759923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current developments in marrow transplantation.
    O'Reilly RJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):92-102. PubMed ID: 3547846
    [No Abstract]   [Full Text] [Related]  

  • 7. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
    Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Allogeneic bone marrow transplantation in 91 patients with acute leukemia (Nagoya Bone Marrow Transplantation Group)].
    Hirabayashi N; Yano K; Yokomaku S; Morishima Y; Iwamura H; Naito K; Kodera Y; Matsuyama K; Nakaide Y; Yamada H
    Rinsho Ketsueki; 1988 Mar; 29(3):313-9. PubMed ID: 3294471
    [No Abstract]   [Full Text] [Related]  

  • 9. Present status of bone marrow transplantation in Japan.
    Masaoka T; Shibata H; Nakamura H; Inoue T
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):139-46. PubMed ID: 3914739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone marrow transplantation with preparation involving total body irradiation of leukemia and malignant lymphoma].
    Inoue T; Masaoka T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):911-21. PubMed ID: 3516076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with interstitial pneumonia following allogeneic bone marrow transplantation for acute leukemia in Japanese experience.
    Inoue T; Masaoka T; Shibata H
    Strahlenther Onkol; 1986 Jun; 162(6):368-73. PubMed ID: 3526600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous bone marrow transplantation in neoplasia.
    Dicke KA; Vellekoop L; Spitzer G; Zander AR; Schell F; Verma DS
    Transplant Proc; 1981 Mar; 13(1 Pt 1):267-9. PubMed ID: 6267751
    [No Abstract]   [Full Text] [Related]  

  • 13. Marrow transplantation: the Seattle experience.
    Storb R
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):75-83. PubMed ID: 3914747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What I needed to know about cyclosporine.
    Li JT
    N C Med J; 1984 Dec; 45(12):771-2. PubMed ID: 6392894
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bone marrow transplantation after intensive chemotherapy].
    Masaoka T
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1650-5. PubMed ID: 3296959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of phorbol esters on normal myeloid precursors and leukemic cells: basis for autologous bone marrow reconstitution in acute nonlymphocytic leukemia using phorbol ester-treated bone marrow from patients in remission.
    Abrahm JL; Gerson SL; Hoxie JA; Tannenbaum SH; Cassileth PA; Cooper RA
    Cancer Res; 1986 Jul; 46(7):3711-6. PubMed ID: 3518922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation of cyclosporine serum and whole blood concentrations with toxicity and efficacy after human marrow transplantation.
    Britton K; Atkinson K; Downs K; Biggs J
    Transplant Proc; 1985 Apr; 17(2):1667-70. PubMed ID: 3885501
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of graft versus host disease following allogeneic bone marrow transplantation.
    Powles RL; Goss GD; Millar J; Maitland J; Borthwick-Clark C; Al-Jundi A
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):133-8. PubMed ID: 3914738
    [No Abstract]   [Full Text] [Related]  

  • 19. Identifying a susceptible period following cyclosporine A-induced tolerance of heart grafts in the rat.
    Lim SM; White DJ; Calne RY
    Transplant Proc; 1987 Oct; 19(5):4218-20. PubMed ID: 3314019
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug interaction between cyclosporin and phenytoin in allogeneic bone marrow transplantation.
    Schmidt H; Naumann R; Jaschonek K; Einsele H; Dopfer R; Ehninger G
    Bone Marrow Transplant; 1989 Mar; 4(2):212-3. PubMed ID: 2650795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.